Ingredion (INGR) said Monday it has stopped operations at its plant protein manufacturing facility in Vanscoy, Canada, affecting about 20 employees.
The company said it intends to sell the facility and the property, though it has yet to enter into a sale agreement.
Ingredion expects to book about $66 million in pre-tax non-recurring charges, including $65 million tied to asset and inventory impairments, along with $1 million for employee-related costs, it added.
Most of the costs will be recognized in Q4, with the remainder spread through the end of 2025, according to the company.
Price: 134.88, Change: -1.65, Percent Change: -1.21
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.